$AKYA
Akoya Biosciences, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024015750 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $18.81M
YoY Change -25.39%
Cost Of Revenue $7.090M
YoY Change -28.66%
Gross Profit $11.72M
YoY Change -23.25%
Gross Profit Margin 62.32%
Selling, General & Admin $14.67M
YoY Change -22.85%
% of Gross Profit 125.15%
Research & Development $4.474M
YoY Change -13.51%
% of Gross Profit 38.16%
Depreciation & Amortization $1.825M
YoY Change -28.99%
% of Gross Profit 15.57%
Operating Expenses $20.07M
YoY Change -25.18%
Operating Profit -$8.349M
YoY Change -27.72%
Interest Expense -$2.625M
YoY Change 17.24%
% of Operating Profit
Other Income/Expense, Net -$36.00K
YoY Change -80.54%
Pretax Income -$10.49M
YoY Change -18.7%
Income Tax $44.00K
% Of Pretax Income
Net Earnings -$10.53M
YoY Change -18.45%
Net Earnings / Revenue -55.98%
Basic Earnings Per Share -$0.21
Diluted Earnings Per Share -$0.21
COMMON SHARES
Basic Shares Outstanding 49.56M 49.50M
Diluted Shares Outstanding 49.50M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.90M
YoY Change -54.33%
Cash & Equivalents $12.56M
Short-Term Investments $23.34M
Other Short-Term Assets $2.967M
YoY Change -15.35%
Inventory $25.21M
Prepaid Expenses
Receivables $12.79M
Other Receivables $0.00
Total Short-Term Assets $76.86M
YoY Change -34.28%
LONG-TERM ASSETS
Property, Plant & Equipment $7.546M
YoY Change -30.41%
Goodwill $18.26M
YoY Change 0.0%
Intangibles $15.27M
YoY Change -15.73%
Long-Term Investments $3.399M
YoY Change
Other Assets $731.0K
YoY Change 11.77%
Total Long-Term Assets $53.11M
YoY Change -11.91%
TOTAL ASSETS
Total Short-Term Assets $76.86M
Total Long-Term Assets $53.11M
Total Assets $130.0M
YoY Change -26.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.760M
YoY Change -26.32%
Accrued Expenses $9.368M
YoY Change -29.0%
Deferred Revenue $6.188M
YoY Change -9.66%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.026M
YoY Change 28.25%
Total Short-Term Liabilities $27.99M
YoY Change -21.2%
LONG-TERM LIABILITIES
Long-Term Debt $75.90M
YoY Change 18.94%
Other Long-Term Liabilities $40.00K
YoY Change -71.43%
Total Long-Term Liabilities $75.94M
YoY Change 18.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.99M
Total Long-Term Liabilities $75.94M
Total Liabilities $116.3M
YoY Change 0.93%
SHAREHOLDERS EQUITY
Retained Earnings -$277.2M
YoY Change 26.44%
Common Stock $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.63M
YoY Change
Total Liabilities & Shareholders Equity $130.0M
YoY Change -26.67%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$10.53M
YoY Change -18.45%
Depreciation, Depletion And Amortization $1.825M
YoY Change -28.99%
Cash From Operating Activities -$9.256M
YoY Change -32.73%
INVESTING ACTIVITIES
Capital Expenditures $434.0K
YoY Change -47.71%
Acquisitions
YoY Change
Other Investing Activities $13.45M
YoY Change
Cash From Investing Activities $13.02M
YoY Change -1668.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -150.0K
YoY Change 7.14%
NET CHANGE
Cash From Operating Activities -9.256M
Cash From Investing Activities 13.02M
Cash From Financing Activities -150.0K
Net Change In Cash 3.613M
YoY Change -124.53%
FREE CASH FLOW
Cash From Operating Activities -$9.256M
Capital Expenditures $434.0K
Free Cash Flow -$9.690M
YoY Change -33.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OperatingExpenses
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.23
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49503272
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48975432
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49370959
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42686065
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OperatingExpenses
akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49522728
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49117738
dei Entity Central Index Key
EntityCentralIndexKey
0001711933
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49522728
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49117738
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40344
dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
896-8401
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AKYA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49563386
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12557000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83125000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
23339000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12786000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16994000
CY2024Q3 us-gaap Inventory Net
InventoryNet
25212000
CY2023Q4 us-gaap Inventory Net
InventoryNet
17877000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2967000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3794000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
76861000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
121790000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7546000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10729000
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3399000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
683000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
699000
CY2024Q3 akya Demo Inventory Net
DemoInventoryNet
792000
CY2023Q4 akya Demo Inventory Net
DemoInventoryNet
893000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15272000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17412000
CY2024Q3 us-gaap Goodwill
Goodwill
18262000
CY2023Q4 us-gaap Goodwill
Goodwill
18262000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4664000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8365000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1763000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1562000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
731000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
657000
CY2024Q3 us-gaap Assets
Assets
129973000
CY2023Q4 us-gaap Assets
Assets
180369000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8760000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11776000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9368000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13433000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2651000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2681000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1026000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
767000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6188000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6688000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27993000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35345000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3093000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3193000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
75902000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
75254000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
113000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4562000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6238000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
778000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
766000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3859000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5765000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000
CY2024Q3 us-gaap Liabilities
Liabilities
116340000
CY2023Q4 us-gaap Liabilities
Liabilities
126599000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49522728
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49117738
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
290860000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283839000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-277237000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-230071000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
13633000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
53770000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129973000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180369000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18814000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60328000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
7090000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
9939000
us-gaap Cost Of Revenue
CostOfRevenue
26839000
us-gaap Cost Of Revenue
CostOfRevenue
30461000
CY2024Q3 us-gaap Gross Profit
GrossProfit
11724000
CY2023Q3 us-gaap Gross Profit
GrossProfit
15276000
us-gaap Gross Profit
GrossProfit
33489000
us-gaap Gross Profit
GrossProfit
39685000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14672000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20251000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53629000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67281000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4474000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6314000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15316000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19614000
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-763000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
262000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-496000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1019000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
CY2024Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1690000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
3087000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
20073000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
26827000
us-gaap Operating Expenses
OperatingExpenses
74507000
us-gaap Operating Expenses
OperatingExpenses
87914000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8349000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11551000
us-gaap Operating Income Loss
OperatingIncomeLoss
-41018000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48229000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2625000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2239000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7843000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6468000
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
521000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1074000
us-gaap Interest And Other Income
InterestAndOtherIncome
2126000
us-gaap Interest And Other Income
InterestAndOtherIncome
2576000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-277000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-338000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10489000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12901000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47012000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52459000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10533000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
us-gaap Net Income Loss
NetIncomeLoss
-47166000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49503272
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48975432
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49370959
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42686065
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10533000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
us-gaap Net Income Loss
NetIncomeLoss
-47166000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
20000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
8000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10513000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12916000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47158000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52515000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
53770000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36000
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
149000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-23484000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2566000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
32723000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2024Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
65000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13149000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2713000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
22249000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10533000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1881000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
13633000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58581000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
94000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18802000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2375000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
42124000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
143000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47817000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2620000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71901000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
110000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2878000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
61973000
us-gaap Profit Loss
ProfitLoss
-47166000
us-gaap Profit Loss
ProfitLoss
-52521000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5802000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6784000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
648000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
541000
us-gaap Share Based Compensation
ShareBasedCompensation
7160000
us-gaap Share Based Compensation
ShareBasedCompensation
7873000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
75000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-496000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1019000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
915000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
1400000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
5000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
1632000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
1782000
akya Change In Inventory Reserve Adjustment
ChangeInInventoryReserveAdjustment
3129000
akya Change In Inventory Reserve Adjustment
ChangeInInventoryReserveAdjustment
2600000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3293000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6367000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-787000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2547000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10379000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7040000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3016000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1262000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2770000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3359000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1706000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1670000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-600000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1239000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41121000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45315000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1414000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3059000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
87328000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8498000
akya Maturities Of Marketable Securities
MaturitiesOfMarketableSecurities
53500000
akya Maturities Of Marketable Securities
MaturitiesOfMarketableSecurities
7000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26744000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3941000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47995000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
75000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
311000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
214000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
94000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
520000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
496000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33000
akya Refunds From Payments Of Deferred Offering Costs
RefundsFromPaymentsOfDeferredOfferingCosts
-150000
akya Refunds From Payments Of Deferred Offering Costs
RefundsFromPaymentsOfDeferredOfferingCosts
-207000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1910000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1709000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2719000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45767000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70584000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4393000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74532000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13240000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78925000
us-gaap Interest Paid Net
InterestPaidNet
6937000
us-gaap Interest Paid Net
InterestPaidNet
5678000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56000
akya Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
790000
akya Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
914000
akya Unpaid Stock Offering Costs
UnpaidStockOfferingCosts
178000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
521000
akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
39295000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-277237000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41121000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18814000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60328000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
763000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1276000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
960000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Cost Basis Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesCostBasisDueOneToTwoYears
3400000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLossesDueOneToTwoYears
1000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosureDueOneToTwoYears
3399000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
35004000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Gains
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedGains
10000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses
2000
CY2024Q3 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
35012000
CY2023Q4 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
76844000
CY2023Q4 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
76844000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18144000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20392000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10598000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9663000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7546000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10729000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
902000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q3 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2024Q3 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2024Q3 akya Demo Inventory Gross
DemoInventoryGross
4466000
CY2023Q4 akya Demo Inventory Gross
DemoInventoryGross
4284000
CY2024Q3 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
3674000
CY2023Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
3391000
CY2024Q3 akya Demo Inventory Net
DemoInventoryNet
792000
CY2023Q4 akya Demo Inventory Net
DemoInventoryNet
893000
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
12786000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
960000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
915000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
960000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29989000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14717000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15272000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29990000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12578000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17412000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2139000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2670000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
714000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2853000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2822000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1956000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1761000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5166000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15272000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4261000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7074000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1410000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1911000
CY2024Q3 akya Accrued Inventory Purchases
AccruedInventoryPurchases
63000
CY2023Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
609000
CY2024Q3 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
1189000
CY2023Q4 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
1096000
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
757000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
711000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1688000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2032000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9368000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13433000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
360000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
448000
CY2024Q3 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
1262000
CY2023Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
702000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
75902000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
75254000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2024Q3 akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49522728
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49117738
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10975187
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8924291
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10533000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12916000
us-gaap Net Income Loss
NetIncomeLoss
-47166000
us-gaap Net Income Loss
NetIncomeLoss
-52521000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49503272
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48975432
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49370959
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42686065
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7861832
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7116558
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18814000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25215000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60328000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70146000
akya Number Of Countries With Concentration Risk
NumberOfCountriesWithConcentrationRisk
0
akya Number Of Countries With Concentration Risk
NumberOfCountriesWithConcentrationRisk
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
28000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
41000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
93000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
105000
CY2024Q3 us-gaap Lease Cost
LeaseCost
652000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1071000
us-gaap Lease Cost
LeaseCost
2422000
us-gaap Lease Cost
LeaseCost
3173000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
672000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2783000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2618000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1104000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
436000
CY2024Q3 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
562000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8175000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
962000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7213000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
539000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
635000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
430000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
383000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
60000
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2047000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
243000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1804000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1116
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0932
us-gaap Operating Lease Payments
OperatingLeasePayments
2076000
us-gaap Operating Lease Payments
OperatingLeasePayments
2328000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
93000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
105000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
520000
akya Financeleaseprincipalpayments1
Financeleaseprincipalpayments1
485000
us-gaap Restructuring Charges
RestructuringCharges
1257000
akya Employee And Equipment Relocation Costs
EmployeeAndEquipmentRelocationCosts
140000
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1690000
CY2024Q3 akya Accrued Liabilities Restructuring Charges
AccruedLiabilitiesRestructuringCharges
19000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015750-index-headers.html Edgar Link pending
0001558370-24-015750-index.html Edgar Link pending
0001558370-24-015750.txt Edgar Link pending
0001558370-24-015750-xbrl.zip Edgar Link pending
akya-20240930.xsd Edgar Link pending
akya-20240930x10q.htm Edgar Link pending
akya-20240930xex10d1.htm Edgar Link pending
akya-20240930xex31d1.htm Edgar Link pending
akya-20240930xex31d2.htm Edgar Link pending
akya-20240930xex32d1.htm Edgar Link pending
akya-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
akya-20240930_def.xml Edgar Link unprocessable
akya-20240930_lab.xml Edgar Link unprocessable
akya-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
akya-20240930_cal.xml Edgar Link unprocessable
akya-20240930_pre.xml Edgar Link unprocessable